乐天堂fun88

  • 695ca7e89b238
    Cancel
    Date：2025-12
    /index.php?a=shows&catid=34&id=917

    Refine Biology recently announced the closing of a several hundred million RMB Series C financing round. The round was led by Xingxiang Asset Management Group, with participation from Royal Power XMXYG Fund as a co-investor. Proceeds from this financing w

  • 69002cbf83f23
    Cancel
    Date：2025-10

    Exclusive Financial Advisor

  • 68c8cefe3d5a9
    Cancel
    Date：2025-09
    /index.php?a=shows&catid=34&id=910

    CEC Capital announced today that its GP/LP service team, dedicated to the private equity secondary market, has successfully completed two significant transactions involving the exit of existing shares. These deals enabled clients to achieve large-scale li

  • 68be8db3cb6ab
    Cancel
    Date：2025-09
    /index.php?a=shows&catid=34&id=908

    iRegene, a biotech company committed to becoming a global leader in universal chemically induced cell therapies, recently announced the successful completion of its Series B+ financing round. The round was jointly led by Northern Light Venture Capital, Ch

  • 68958fa4e3ca7
    Cancel
    Date：2025-08

    Exclusive Financial Advisor to BridgeDP

  • 687dac9172653
    Cancel
    Date：2025-06
    /index.php?a=shows&catid=34&id=904

    On the evening of June 30, 2025, Suning.com (002024) announced that its first interim shareholders' meeting of 2025 had approved the Proposal on the Sale of Subsidiary Equity by Suning International Holding’s Subsidiary Carrefour China Holdings N.V. CEC Capital acted as the exclusive financial advisor to Suning.com for this transaction.

  • 6823080abb87c
    Cancel
    Date：2025-04

    Exclusive Financial Advisor to IREGENE

  • 67e0cbac60773
    Cancel
    Date：2025-03
    /index.php?a=shows&catid=34&id=873

    Recently, Geneus Technologies, a leading domestic company in nanopore sequencing technology, announced the completion of a nearly RMB 100 million B++ round of financing. This round of funding was led by CDBT Group, with participation from Si Chuan Venture

  • 67b5a4b6895ca
    Cancel
    Date：2025-02

    Exclusive Financial Advisor to QL Biopharm


【网站地图】